Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016

1

• Peripheral Neuropathy (Sensory Neuropathy) -
  Pipeline Review, H1 2016

2
Summary
Peripheral Neuropathy (Sensory Neuropathy) -
Pipeline Review, H1 2016, provides an overview
of the Peripheral Neuropathy (Sensory Neuropathy)
pipeline landscape. The report provides
comprehensive information on the therapeutics
under development for Peripheral Neuropathy
(Sensory Neuropathy), complete with analysis by
stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and
molecule type. The report also covers the
descriptive pharmacological action of the
therapeutics, its complete research and
development history and latest news and press
releases. Additionally, the report provides an
overview of key players involved in therapeutic
development for Peripheral Neuropathy (Sensory
Neuropathy) and features dormant and discontinued
projects.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
3
This report features investigational drugs from
across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built
using data and information sourced from
proprietary databases, company/university
websites, clinical trial registries, conferences,
SEC filings, investor presentations and featured
press releases from company/university sites and
industry-specific third party sources. Drug
profiles featured in the report undergoes
periodic review following a stringent set of
processes to ensure that all the profiles are
updated with the latest set of information.
Additionally, various dynamic tracking processes
ensure that the most recent developments are
captured on a real time basis. The report helps
in identifying and tracking emerging players in
the market and their portfolios, enhances
decision making capabilities and helps to create
effective counter strategies to gain competitive
advantage.
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
4
Scope
- The report provides a snapshot of the global
therapeutic landscape of Peripheral Neuropathy
(Sensory Neuropathy) - The report reviews
pipeline therapeutics for Peripheral Neuropathy
(Sensory Neuropathy) by companies and
universities/research institutes based on
information derived from company and
industry-specific sources - The report covers
pipeline products based on various stages of
development ranging from pre-registration till
discovery and undisclosed stages - The report
features descriptive drug profiles for the
pipeline products which includes, product
description, descriptive MoA, RD brief,
licensing and collaboration details other
developmental activities
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
5
Scope
- The report reviews key players involved
Peripheral Neuropathy (Sensory Neuropathy)
therapeutics and enlists all their major and
minor projects - The report assesses Peripheral
Neuropathy (Sensory Neuropathy) therapeutics
based on drug target, mechanism of action (MoA),
route of administration (RoA) and molecule
type - The report summarizes all the dormant and
discontinued pipeline projects - The report
reviews latest news related to pipeline
therapeutics for Peripheral Neuropathy (Sensory
Neuropathy)
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
6
Reasons to buy
-Gain strategically significant competitor
information, analysis, and insights to formulate
effective RD strategies - Identify emerging
players with potentially strong product portfolio
and create effective counter-strategies to gain
competitive advantage - Identify and understand
important and diverse types of therapeutics under
development for Peripheral Neuropathy (Sensory
Neuropathy) - Identify potential new clients or
partners in the target demographic - Develop
strategic initiatives by understanding the focus
areas of leading companies
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
7
Reasons to buy
- Plan mergers and acquisitions effectively by
identifying key players and its most promising
pipeline therapeutics - Devise corrective
measures for pipeline projects by understanding
Peripheral Neuropathy (Sensory Neuropathy)
pipeline depth and focus of Indication
therapeutics - Develop and design in-licensing
and out-licensing strategies by identifying
prospective partners with the most attractive
projects to enhance and expand business potential
and scope - Modify the therapeutic portfolio by
identifying discontinued projects and
understanding the factors that drove them from
pipeline
W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
8
Table of Contents

1. Peripheral Neuropathy (Sensory Neuropathy) -
   Overview 10
2. Peripheral Neuropathy (Sensory Neuropathy) -
   Comparative Analysis 11
3. Peripheral Neuropathy (Sensory Neuropathy) -
   Therapeutics under Development by Companies 12
4. Peripheral Neuropathy (Sensory Neuropathy) -
   Therapeutics under Investigation by
   Universities/Institutes 14
5. Peripheral Neuropathy (Sensory Neuropathy) -
   Pipeline Products Glance 15
6. Peripheral Neuropathy (Sensory Neuropathy) -
   Products under Development by Companies 19
7. Peripheral Neuropathy (Sensory Neuropathy) -
   Products under Investigation by
   Universities/Institutes 20
8. Peripheral Neuropathy (Sensory Neuropathy) -
   Companies Involved in Therapeutics Development 21
9. Peripheral Neuropathy (Sensory Neuropathy) -
   Therapeutics Assessment 36
10. Drugs for Peripheral Neuropathy - Drug Profile 54

W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com
9
To view the full Executive Summary and Table
of Contents, please visit Peripheral
NeuropathyPipeline Review, H1 2016 Contact
Us-Call India 91-22-27810772/73Email id
poonam_at_bharatbook.comWebsite
www.bharatbook.comOur Blog https//www.bharatbo
ok.com/blog/

W www.bharatbook.com , T  91 22 27810772,
27810773, E  poonam_at_bharatbook.com